TP53 and lung carcinoma: The top enriched pathways included the “cell cycle” (p‐value = 4.90 × 10−11) and the “p53 pathway” (p‐value = 6.87 × 10−3) as significantly affected, suggesting that these genes play roles in the cell cycle and lung cancer progression.